Aptar Pharma and Gateway Analytical are excited to announce an upcoming webinar that promises to be an indispensable resource for professionals in the pharmaceutical industry. Titled “The Art of CCIT: Deterministic Method Selection,” this educational session is designed to address the critical aspects of Container Closure Integrity Testing (CCIT) in pharmaceutical packaging. The webinar is scheduled to review the nuances of deterministic methods, renowned for their reliability and efficiency in ensuring product safety and efficacy.
Container Closure Integrity is a cornerstone in safeguarding pharmaceuticals, making the selection of a robust testing method paramount. This webinar will provide an exhaustive overview of deterministic methods, which stand out for their accuracy and dependability. Attendees will gain insights into various deterministic testing techniques, such as vacuum decay, high voltage leak detection, and laser-based methods. The session aims to elucidate the principles behind these methods, their benefits, and their limitations, offering a comprehensive understanding that is pivotal for informed decision-making.
The webinar will also include the vital considerations in choosing the most appropriate deterministic method for CCIT. Factors such as the type of container, the characteristics of the product, the production environment, and regulatory demands will be thoroughly explored. Emphasis will be placed on the importance of selecting a method that not only meets but exceeds application requirements to ensure both optimal performance and regulatory compliance.
The webinar is structured with four key learning objectives to maximize the attendees’ takeaways. These include understanding the advantages of deterministic over probabilistic testing, discovering the diverse deterministic methods offered by Gateway Analytical, along with their principles, benefits, and limitations. Two other learning objectives include learning critical factors in selecting the appropriate method for specific container types and reviewing illustrative case studies to present possible scenarios and solutions.
The webinar will have two subject matter experts presenting, these are Antonio Scatena, Director of Sales and Marketing, at Gateway Analytical, and Patrick Dayton, Project Manager, at Gateway Analytical, who bring a wealth of knowledge and experience to the table, promising to make this session highly informative and engaging. The webinar is tailored for a wide range of professionals within the pharmaceutical sector, including Heads of Packaging, Validation, Research and Development, Analytical R&D, Manufacturing, Quality Control, and Quality Assurance, among others.
Don’t miss this opportunity to elevate your understanding of CCIT and ensure your practices meet the highest standards of safety and efficacy.
For more information and to register for this enlightening webinar, please click on the links below.
Register for 9am London Session
Register for 3:30pm London Session
About Aptar Pharma
Aptar Pharma is part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has approximately 13,500 dedicated employees in 20 countries.
For more information, visit www.aptar.com/pharmaceutical
About Gateway Analytical
Gateway Analytical, an Aptar Pharma Company, is a specialized analytical testing laboratory that businesses around the world trust to provide solutions for their most challenging foreign particulate characterization and materials analysis needs. Gateway Analyticals expert scientists, specialized test methods and comprehensive suite of instrumentation deliver the fast, accurate and reliable results that customers in the pharmaceutical, materials and medical device industries demand. With a strong focus on quality, Gateway Analytical is cGMP-compliant, FDA registered and inspected, and DEA licensed.
For more information, visit www.gatewayanalytical.com
